International Journal of Hypertension

Hypertension and Cardiometabolic Risk Factors

Publishing date
19 Apr 2013
Submission deadline
30 Nov 2012

1Department of Clinical Medicine, State University of Rio de Janeiro, 20551-030 Rio de Janeiro, RJ, Brazil

2Department of Internal Medicine, University Hospital of Pisa, Pisa

3Department of Internal Medicine, State University of Rio de Janeiro, 20551-030 Rio de Janeiro, RJ, Brazil

4Laboratory of Cardiovascular Investigation, Oswaldo Cruz Institute, 21040-360 Rio de Janeiro, RJ, Brazil

Hypertension and Cardiometabolic Risk Factors


Despite the availability of efficient antihypertensive drugs, blood pressure control rates are not satisfactory in hypertensive patients all over the world. The association of hypertension with other criteria for metabolic syndrome, such as an elevated waist circumference, fasting glucose and triglycerides, and reduced HDL-cholesterol levels, seems to contribute to the failure of treatment efficacy. Furthermore, these metabolic risk factors are also associated to adverse cardiovascular outcomes, especially in the presence of some cardiac risk markers including family history of premature myocardial infarction or stroke, microalbuminuria, and elevated C-reactive protein among others. The relationship between hypertension and several vascular and metabolic abnormalities, characterizing the cardiometabolic syndrome, is the main subject of this special issue. Potential topics include, but are not limited to:

  • The role of inflammation and oxidative stress in hypertension
  • Pathophysiological alterations induced by metabolic risk factors
  • Obesity, abdominal fat, and hypertension
  • New evidences about insulin resistance, diabetes, and hypertension
  • The impact of dyslipidemia in hypertensive patients
  • Relevance of hypertension in metabolic syndrome
  • Mechanisms of left ventricular hypertrophy in obesity
  • Assessment of cardiovascular risk in hypertensive patients
  • Effects of metabolic risk factors on microcirculation
  • Early manifestations of atherosclerosis accelerated by metabolic factors: endothelial dysfunction, increased vascular stiffness, and carotid intima-media thickening
  • Nutritional approach of metabolic factors in hypertension
  • Effects of antihypertensive and oral hypoglycemic drugs, statins, and other hypolipidemic agents

Before submission authors should carefully read over the journal's Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

International Journal of Hypertension
 Journal metrics
Acceptance rate36%
Submission to final decision120 days
Acceptance to publication28 days
Impact Factor1.132

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.